This case is a story with no drama. No sudden crisis. No last-minute rescues. It’s about a clinical trial that ran perfectly from start to finish. And that in itself is a story worth telling.
The sponsor needed to test a new nonsteroidal antiinflammatory drug (NSAID). They had worked with Premier Research before, and knew our track record in analgesia studies: More than 870 pain trials treating over 110,000 patients, including trials for all of the NSAID analgesics on the market today.
Our experience enabled us to quickly line up what we knew were the 40 best sites in the country for this type of analgesia study. The sites hadn’t done any similar studies recently, so we knew they had lots of patients geared up and ready to go.